Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tg Therapeutics (TGTX) Other financing activities: 2009-2024

Historic Other financing activities for Tg Therapeutics (TGTX) over the last 11 years, with Dec 2024 value amounting to $889,000.

  • Tg Therapeutics' Other financing activities was N/A to $31,000 in Q4 2024 from the same period last year, while for Dec 2024 it was $1.3 million, marking a year-over-year change of. This contributed to the annual value of $889,000 for FY2024, which is 611.20% up from last year.
  • As of FY2024, Tg Therapeutics' Other financing activities stood at $889,000, which was up 611.20% from $125,000 recorded in FY2023.
  • Tg Therapeutics' 5-year Other financing activities high stood at $1.0 million for FY2021, and its period low was $125,000 during FY2023.
  • Its 2-year average for Other financing activities is $507,000, with a median of $507,000 in 2023.
  • Data for Tg Therapeutics' Other financing activities shows a peak YoY surged of 611.20% (in 2024) over the last 5 years.
  • Over the past 3 years, Tg Therapeutics' Other financing activities (Yearly) stood at $1.0 million in 2021, then reached $125,000 in 2023, then skyrocketed by 611.20% to $889,000 in 2024.